Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)
Technical Analysis Report for NASDAQ stock ALNY Alnylam Pharmaceuticals. Dated: 03 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Opened at 321.37 and Closed at: 318.65, which is -2.01% of previous session's close. It moved within a range of 315.20 and 324.06
The session was a Bearish session with an average volume of 947600, which is -37.43% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 3 days back on short term averages
Support for tomorrow is 312.5 and resistance for tomorrow is 321.36
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 314.55, 310.44 resistance for tomorrow's hourly charts is 323.41, 328.16
10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 330.57 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 327.6 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 357.9 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 402.99 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Alnylam Pharmaceuticals is 391.12 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Alnylam Pharmaceuticals is at 327.6 and 200 DMA is at 391.12, while 50 DMA and 100 DMA are at 357.9 and 402.99 respectively
Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 327.6 and 20 EMA is at 332.58
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Tue Mar | 318.65 | 327.6 | 332.58 |
| 02 Mon Mar | 325.07 | 329.26 | 334.05 |
| 27 Fri Feb | 332.92 | 329.96 | 334.99 |
| 26 Thu Feb | 331.24 | 330.22 | 335.21 |
| 25 Wed Feb | 327.36 | 330.99 | 335.63 |
| 24 Tue Feb | 332.85 | 332.1 | 336.5 |
Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 357.9 and 50 EMA is at 355.88
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Tue Mar | 318.65 | 357.9 | 355.88 |
| 02 Mon Mar | 325.07 | 359.45 | 357.4 |
| 27 Fri Feb | 332.92 | 360.79 | 358.72 |
| 26 Thu Feb | 331.24 | 361.95 | 359.77 |
| 25 Wed Feb | 327.36 | 363.16 | 360.93 |
| 24 Tue Feb | 332.85 | 364.56 | 362.3 |
Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 402.99 and 100 EMA is at 377.22
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Tue Mar | 318.65 | 402.99 | 377.22 |
| 02 Mon Mar | 325.07 | 404.31 | 378.4 |
| 27 Fri Feb | 332.92 | 405.65 | 379.48 |
| 26 Thu Feb | 331.24 | 406.84 | 380.42 |
| 25 Wed Feb | 327.36 | 408.09 | 381.41 |
| 24 Tue Feb | 332.85 | 409.43 | 382.5 |
Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 391.12 and 200 EMA is at 373.18
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Tue Mar | 318.65 | 391.12 | 373.18 |
| 02 Mon Mar | 325.07 | 390.86 | 373.73 |
| 27 Fri Feb | 332.92 | 390.57 | 374.22 |
| 26 Thu Feb | 331.24 | 390.26 | 374.64 |
| 25 Wed Feb | 327.36 | 389.86 | 375.08 |
| 24 Tue Feb | 332.85 | 389.51 | 375.56 |
Summit Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Summit Therapeutics, about 14.25% more returns!
Siga Technologies has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Siga Technologies, about 1.88% more returns!
Minerva Neurosciences has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 56.36% more returns!
Neurocrine Biosciences has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 4.59% more returns!
Alnylam Pharmaceuticals has performed better than Medicinova Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Mannkind Corporation in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Lipocine Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Lipocine Inc, about 12.39% more returns!
Kezar Life has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Kezar Life, about 26.62% more returns!
Kura Oncology has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Kura Oncology, about 14.79% more returns!
Alnylam Pharmaceuticals has performed better than Atossa Genetics in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Caredx Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Caredx Inc, about 8.77% more returns!
Alnylam Pharmaceuticals has performed better than Collplant Holdings in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Immuron has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Immuron, about 0.82% more returns!
Insmed Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Insmed Inc, about 5.89% more returns!
Innoviva Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Innoviva Inc, about 13.28% more returns!
Ionis Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Ionis Pharmaceuticals, about 2.01% more returns!
Iradimed Corporation has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Iradimed Corporation, about 20.58% more returns!
Alnylam Pharmaceuticals Technical analysis of indicators
Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.
Alnylam Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Alnylam Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 330.99 and Alnylam Pharmaceuticals ALNY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.
Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALNY Experts View which covers a lot of information including buying and selling signals
ALNY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


